FDA is extending the comment period on the proposed rule that appeared in the Federal Register of April 25, 2014
79 FR 23141. Submit either electronic or written comments by August 8, 2014.
ADDRESSES: You may submit comments, identified by Agency name, Docket No. FDA-2014-N-0189, and/or Regulatory Information Number RIN 0910-AG38, by any of the following methods:
Electronic Submissions: Submit electronic comments in the following way:
● Federal eRulemaking Portal: http://www.regulations.gov
Follow the instructions for submitting comments.
Submit written submissions in the following ways:
● Mail/Hand delivery/Courier for paper submissions: Division of DocketsManagement HFA-305, Food and Drug Administration, 5630 Fishers Lane, rm. 1061,Rockville, MD 20852.
Instructions: All submissions received must include the Agency name, Docket No. FDA-2014-N-0189, and RIN 0910-AG38 for this rulemaking. All comments received may be posted without change to http://www.regulations.gov, including any personal information provided. For additional information on submitting comments, see the “Comments” heading of the SUPPLEMENTARY INFORMATION section of this document.
Docket: For access to the docket to read background documents or comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the “Search” box and follow the prompts
go to the Division of Dockets Management,
5630 Fishers Lane, rm. 1061,
Rockville, MD 20852
FOR FURTHER INFORMATION CONTACT:
Center for Tobacco Products, Food and Drug Administration, Document Control Center
Bldg. 71, rm. G335, 10903
New Hampshire Ave., Silver Spring, MD 20993-0002